Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 210 participants.
Also called NCT07563673
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 210 participants
- Sponsor
- Registry
-
NCT07563673
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07563673. Randomized; no masking; primary purpose treatment. Start 2026-05-01 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Early Low-dose ASpirin Use After Intravenous Thrombolysis for Acute Ischemic Cerebral Infarction(ELASTIC)
- Acronym
- ELASTIC
- Condition
- Cerebral Infarction
- Condition
- Thrombolysis
- Intervention (Drug)
- Aspirin (Early, 2h)
- Intervention (Drug)
- Aspirin (Standard, 24h)
- Lead sponsor
- Beijing Chao Yang Hospital
Record details
- Record id
cardio:ct-nct07563673- Content hash
0df90fc4df4416606f918dfc1e26c60acbe708c452c3e40dd3043ea6063b5f11